NARI Inari Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NARI

Price (delayed)

$53.83

Market cap

$3.13B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.4

Enterprise value

$3.09B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
The revenue rose by 26% year-on-year and by 5% since the previous quarter
NARI's gross profit is up by 25% YoY and by 5% QoQ
The equity is up by 4.8% year-on-year but it is down by 3.8% since the previous quarter
The quick ratio has plunged by 74% YoY and by 14% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://inarimedical.com
Peers: OFIX NVRO

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
58.14M
Market cap
$3.13B
Enterprise value
$3.09B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.98
Price to sales (P/S)
5.99
EV/EBIT
N/A
EV/EBITDA
1,574.48
EV/Sales
5.94
Earnings
Revenue
$520.66M
EBIT
-$10.41M
EBITDA
$1.97M
Free cash flow
$18.51M
Per share
EPS
-$0.4
Free cash flow per share
$0.32
Book value per share
$7.72
Revenue per share
$8.99
TBVPS
$5.29
Balance sheet
Total assets
$661.78M
Total liabilities
$214.55M
Debt
$31.49M
Equity
$447.23M
Working capital
$147.28M
Liquidity
Debt to equity
0.07
Current ratio
2.71
Quick ratio
2.1
Net debt/EBITDA
-18.18
Margins
EBITDA margin
0.4%
Gross margin
87.7%
Net margin
-4.5%
Operating margin
-3.8%
Efficiency
Return on assets
-3.9%
Return on equity
-5.2%
Return on invested capital
-3.3%
Return on capital employed
-1.8%
Return on sales
-2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
-2.48%
1 week
-1.95%
1 month
15.79%
1 year
-11.61%
YTD
-17.08%
QTD
11.8%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$520.66M
Gross profit
$456.44M
Operating income
-$19.57M
Net income
-$23.62M
Gross margin
87.7%
Net margin
-4.5%
The company's operating margin rose by 49% YoY but it fell by 36% QoQ
The operating income has contracted by 39% from the previous quarter but it has grown by 36% YoY
Inari Medical's net margin has increased by 35% YoY
The revenue rose by 26% year-on-year and by 5% since the previous quarter

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
N/A
P/B
6.98
P/S
5.99
EV/EBIT
N/A
EV/EBITDA
1,574.48
EV/Sales
5.94
The EPS has increased by 23% year-on-year
The price to book (P/B) is 45% lower than the 5-year quarterly average of 13.0 and 4.7% lower than the last 4 quarters average of 7.5
The equity is up by 4.8% year-on-year but it is down by 3.8% since the previous quarter
The P/S is 58% below the 5-year quarterly average of 14.5 and 14% below the last 4 quarters average of 7.1
The revenue rose by 26% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Inari Medical business performance
The return on sales has surged by 66% year-on-year
NARI's return on invested capital is up by 44% year-on-year
The company's return on assets rose by 32% YoY
The return on equity has increased by 24% year-on-year

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The company's total liabilities has surged by 169% YoY and by 2.5% QoQ
The quick ratio has plunged by 74% YoY and by 14% from the previous quarter
Inari Medical's debt is 93% less than its equity
NARI's debt to equity is down by 13% YoY
Inari Medical's debt has decreased by 4.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.